STANDARD BIOTOOLS INC. (LAB) Stock Profile — Insider Trades & Financials

Revenue$23.8M

Net Income$19.3M

EPS$-0.25

Gross Margin47.8%

Market Cap$362.3M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Michael Egholm

CEO & Executive Director

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.

Employees: 615
Headquarters: BOSTON, MA, United States
Website: www.standardbio.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

4.54%

ROA?

3.40%

D/E Ratio?

0.34

Op. Margin?

-103.57%

📊

Profitability Ratios

Net Margin?

81.04%

Loading company sections...

STANDARD BIOTOOLS INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness